Cash round sets up trial of InteRNA’s microRNA for cancer
Pharma Phorum
FEBRUARY 9, 2021
InteRNA is focusing on the development of gene-silencing drugs based on microRNA, naturally occurring, non-coding strands of RNA that are thought to regulate gene expression in cells. Dutch biotech InteRNA Technologies has raised €18.5
Let's personalize your content